Page 10 - BH-2-1
P. 10

Brain & Heart                                                        Hypochloremia in refractory heart failure



              The osmotic gradient between the gut lumen and     Kidneys are the key organs in HF-related congestion
            mucosa is what causes fluid to be secreted into the intestinal   and volume overload. They are the main organs affected
            tract, and it is mainly caused by Cl and, to a lesser degree,   by hypoperfusion and are the sites of primary counter-
            HCO  ions. Under normal circumstances, the kidneys   regulatory responses. Moreover, the kidneys are a target
                3
            regulate the daily dietary intake of NaCl. The entire   of prolonged diuretic therapy in patients with cardiac and
            length of human kidney nephrons expresses Cl channels,   renal disorders. However, the long-term use of diuretics
            which take part in transepithelial transport, acidification   results in decreased responsiveness and further renal
            of intracellular vesicles, and cell volume regulation. The   deterioration in the form of diuretic resistance. 26
            macula densa in the juxtaglomerular part of the kidney
            mainly uses Cl instead of Na to sense salt and volume status.   7. Diuretic resistance
            When the volume is normal, there is less salt reabsorption   There is no consensus in the literature among clinicians
            in the proximal tubule, with more NaCl reaching the   regarding the definition of diuretic resistance. However,
            macula. This adequate NaCl sensed at the macula, in turn,   it  is agreed  that the decreased diuretic  and natriuretic
            inhibits renin secretion and blocks RAAS. This effect is   effects of loop diuretics worsen fluid overload. Diuretic
            independent of Na; however, the effect does not occur   resistance affects 25 – 30% of patients with HF and causes
            when the macula is exposed to NA bicarbonate (NaHCO )   fluid retention despite higher doses of loop diuretics. 26,27
                                                         3
            instead of NaCl. This neurohormonal mechanism suggests   Many physiological alterations in CHF can cause changes
            that Cl is mainly responsible for renin and volume status   in drug pharmacokinetics, such as problems in drug
            regulation, supporting the Cl theory. 23-25        absorption, distribution, metabolism, and excretion of
              HF  causes  decreased cardiac output  and, hence,   diuretics. However, these changes alone do not explain
            reduces renal blood flow. Low renal perfusion triggers a   the  diuretic  resistance  observed  in  HF. 28,29  Patients with
            compensatory alteration of renal arteriolar resistance,   CHF, when compared to healthy subjects, have a decreased
            along with renal salt and water retention, to maintain   drug absorption rate, which causes a delay in achieving a
            plasma volume. Notably, activation of the RAAS, non-  threshold drug dose with the resultant diuretic resistance.
            osmotic  vasopressin  release,  and  increased  sympathetic   Surprisingly, the bioavailability of diuretics remains the
            nervous tone in individuals with HF aid in this process   same, which explains these changes, preferably due to gut
                                                                         29,30
            (Figure 1). Moreover, renal beta-adrenergic receptors seem   edema in HF.
            to play an essential role in the initiation and maintenance   In general, loop diuretics reach the renal tubular fluid
            of renal compensatory mechanisms. 26               through secretion from an organic anion transport channel
































            Figure 1. Interplay of pathophysiologic mechanisms in HF. Image created using BioRender.com.
            Abbreviations: CO: Cardiac output; LVEDP: Left ventricular end-diastolic pressure; RA: Right atrial; RAAS: Renin angiotensin aldosterone system.


            Volume 2 Issue 1 (2024)                         4                         https://doi.org/10.36922/bh.2257
   5   6   7   8   9   10   11   12   13   14   15